People: Cellmid Ltd (CDY.AX)

CDY.AX on Australia Stock Exchange

0.03AUD
22 Sep 2014
Price Change (% chg)

$-0.00 (-3.57%)
Prev Close
$0.03
Open
$0.03
Day's High
$0.03
Day's Low
$0.03
Volume
259,285
Avg. Vol
1,941,768
52-wk High
$0.05
52-wk Low
$0.02

Search Stocks

Summary

Name Age Since Current Position

David King

2008 Independent Non-Executive Chairman of the Board

Maria Halasz

2007 Chief Executive Officer, Managing Director, Executive Director

Nicholas Falzon

2013 Financial Controller, Joint Company Secretary

Jillian McGregor

2013 Joint Company Secretary

Graeme Kaufman

2012 Non-Executive Director

Martin Rogers

2012 Non-Executive Director

Biographies

Name Description

David King

Dr. David William King , Ph.D., has been Independent Non-Executive Chairman of the Board of Cellmid Ltd since January 18, 2008. He is Fellow of The Australian Institute of Company Directors, Fellow of the Australian Institute of Geoscientists and holds a Doctorate in Philosophy in Seismology from the Australian National University in 1974. He also obtained a Bachelor of Science in Physics from University of East Anglia in 1968 and a Master of Science in Geophysics from University of London in 1969. He is Member of the Audit Committee, and Remuneration Committee. He is Director of Robust Resources Limited and Republic Gold Limited and was Director of Gas2Grid Limited, Ausmon Resources Limited, Sapex Limited and Eastern Star Gas Limited.

Maria Halasz

Ms. Maria Halasz has been Chief Executive Officer, Managing Director and Executive Director of Cellmid Ltd since April 16, 2007. She is a Graduate of the Australian Institute of Company Directors and holds a Bachelor of Science degree in Microbiology and a Masters of Business Administration from University of Western Australia. She has over 18 years of experience in biotechnology companies; initially working in executive positions in biotechnology firms, then managing investment funds and later holding senior positions in corporate finance specializing in life sciences.

Nicholas Falzon

Mr. Nicholas Falzon has been Financial Controller and Joint Company Secretary of Cellmid Ltd since July 16, 2013. As a partner at Lawler Partners, he works with a number of listed and unlisted companies advising them on all aspects of their financial management. He holds a Bachelor of Business at UTS and is a member of the Institute of Chartered Accountants of Australia.

Jillian McGregor

Ms. Jillian McGregor has been Joint Company Secretary of Cellmid Ltd since July 16, 2013. She has worked as a corporate lawyer for more than 15 years in mid and top tier Australian law firms. During this time she has provided Corporations Act and ASX Listing Rule advice to many ASX listed companies including advice on related party transactions, capital raising requirements, and meeting continuous disclosure requirements. Ms. McGregor holds a Bachelor of Commerce and Law from University of New South Wales.

Graeme Kaufman

Mr. Graeme Kaufman has been Non-Executive Director of Cellmid Ltd since August 27, 2012. He has over 45 years' experience in biotechnology spanning technical, commercial and financial areas. Having worked for 34 years at CSL Limited, Australia's biopharmaceutical company, he held senior positions including Production Director, General Manager Finance and General Manager Biosciences. He holds a Bachelor of Science and a Masters of Business Administration from Melbourne University. He is Chairman of the Audit Committee and member of the Remuneration and Nomination Committee. He holds directorship in Bionomics Ltd and IDT Australia Ltd.

Martin Rogers

Dr. Martin Frederick Rogers has been Non-Executive Director of Cellmid Ltd since September 19, 2012. He is the former CEO and current non-executive director of Prima BioMed Ltd. He has a depth of experience in incubating companies and publicly listed organisations. Mr. Rogers has experience in all aspects of financial, strategic and operational management and has raised over $100m in equity. He is Member of the Audit Committee and member of the Remuneration Committee. He holds directorship in Consegna Limited, Prima BioMed Ltd and OncoSil Medical Limited.

Basic Compensation

Name Fiscal Year Total

David King

70,850

Maria Halasz

436,000

Nicholas Falzon

--

Jillian McGregor

--

Graeme Kaufman

--

Martin Rogers

--
As Of 29 Jun 2013

Options Compensation

Search Stocks